Armstrong E P, Proteau D
Department of Pharmacy Practice, College of Pharmacy, University of Arizona, Tucson 85721, USA.
Ann Pharmacother. 1996 Oct;30(10):1088-91. doi: 10.1177/106002809603001004.
To determine the desirability or perceived need of retrospective drug utilization review (DUR) software system characteristics.
A 32-item questionnaire.
Ambulatory DUR directors covering more than 33 million patients.
Medicaid DUR directors from 49 states and the District of Columbia.
Five-point Likert scale measures of importance of system and vendor characteristics.
A 100% response rate was achieved. Respondents rated the ability to change or modify criteria as very important and thought it was important to receive criteria sets from software vendors. Respondents believed cost-savings methodologies should be clearly defined and false positive DUR criteria should be minimized.
Through the implementation of the Omnibus Budget Reconciliation Act of 1990, considerable experience in ambulatory DUR programs has been achieved. Respondents believed the ability to change DUR criteria was very important and they thought it was important to have a set of criteria supplied from software vendors. Critical issues of criteria development, cost-savings methodologies, minimizing false positive criteria, and outcomes assessment from DUR programs were important issues to DUR directors.
确定回顾性药物利用审查（DUR）软件系统特性的可取性或感知需求。
一份包含32个条目的问卷。
负责超过3300万患者的门诊DUR主任。
来自49个州和哥伦比亚特区的医疗补助DUR主任。
对系统和供应商特性重要性的五点李克特量表测量。
实现了100%的回复率。受访者将更改或修改标准的能力评为非常重要，并认为从软件供应商处获得标准集很重要。受访者认为应明确界定成本节约方法，且应尽量减少假阳性DUR标准。
通过实施1990年的《综合预算协调法案》，门诊DUR项目积累了相当多的经验。受访者认为更改DUR标准的能力非常重要，并且他们认为由软件供应商提供一套标准很重要。标准制定、成本节约方法、尽量减少假阳性标准以及DUR项目的结果评估等关键问题对DUR主任来说是重要问题。
